// App-Quantinova.ai

2905-05 : THE ABSORB TRIAL: EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 4 YEAR CLINICAL RESULTS OF COHORT B

Researchers

Presenter

  • Evald Hoej Christiansen

Principal Investigators

  • N/A

Medical Centers

  • Department of Urology, Aarhus N, Denmark.

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary artery lesions

  • Venous thrombosis

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved